Clinical trial
Mycophenolate Mofetil in Membranous Nephropathy
NCT00135967 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00135967 |
|---|---|
| Title | Mycophenolate Mofetil in Membranous Nephropathy |
| Official title | Treatment of Patients With Membranous Nephropathy and Renal Insufficiency With Mycophenolate Mofetil and Prednisone: a Pilot Study |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Glomerulonephritis, Membranous |
| Intervention type | Drug |
| Interventions | mycophenolate mofetil orally 1000 mg twice a day (BID), prednisone 0, 5 mg/kg orally on alternate days, intravenous (i.v.) methylprednisolone 1000 mg, total 9 |
| Enrollment | 30 |
| Start date | May 1, 2002 |
| First posted | Aug 26, 2005 |
| Last update posted | Dec 6, 2005 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: